Rankings
▼
Calendar
UTHR FY 2019 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
UTHR
United Therapeutics Corporation
$24B
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1.4B
-11.0% YoY
Gross Profit
$1.3B
91.9% margin
Operating Income
-$188M
-12.9% margin
Net Income
-$105M
-7.2% margin
EPS (Diluted)
$-2.39
Cash Flow
Operating Cash Flow
-$207M
Free Cash Flow
-$290M
Stock-Based Comp.
$45M
Balance Sheet
Total Assets
$3.9B
Total Liabilities
$1.1B
Stockholders' Equity
$2.8B
Cash & Equivalents
$738M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.4B
$1.6B
-11.0%
Gross Profit
$1.3B
$1.4B
-6.9%
Operating Income
-$188M
$805M
-123.3%
Net Income
-$105M
$589M
-117.7%
← Q4 2018
All Quarters
Q1 2019 →